By David Kappos In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in the United States. Victoza is one of the first GLP-1 drugs -- the class of wildly popular diabetes and obesity treatments that includes Ozempic and Wegovy -- to go off-patent. Within just a…
